|
Delayed
Australian S.E.
03:00:45 10/11/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.5325 AUD | +2.40% |
|
+6.50% | -41.16% |
| 23/10 | Proteomics International Laboratories Set to Start National Rollout of Two Blood Tests | MT |
| 22/10 | Healius Limited - Shareholder/Analyst Call |
| Market Cap | 378M 261M 233M 214M 194M 368M 24.45B 2.56B 1.02B 13.09B 979M 958M 41.22B | P/E 2027 * |
96.3x | P/E 2028 * | -110x |
|---|---|---|---|---|---|
| Enterprise Value | 1.15B 797M 712M 655M 594M 1.13B 74.74B 7.83B 3.12B 40.01B 2.99B 2.93B 126B | EV / Sales 2027 * |
0.83x | EV / Sales 2028 * | 0.82x |
| Free-Float |
77.69% | Yield 2027 * |
-
| Yield 2028 * | 1.51% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| HLS | Delayed | |
Deutsche Boerse AG
| PGZ | Delayed | |
|
Börse Stuttgart
| PGZ | Delayed |
Last Transcript: Healius Limited
| 1 day | +2.40% | ||
| 1 week | +6.50% | ||
| Current month | +7.58% | ||
| 1 month | +36.54% | ||
| 3 months | +29.88% | ||
| 6 months | +5.45% | ||
| Current year | -41.16% |
| 1 week | 0.48 |  | 0.54 |
| 1 month | 0.36 | | 0.54 |
| Current year | 0.3 | | 1.05 |
| 1 year | 0.3 | | 1.07 |
| 3 years | 0.3 | | 1.95 |
| 5 years | 0.3 | | 5.54 |
| 10 years | 0.3 | | 5.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Anderson
CEO | Chief Executive Officer | - | 05/03/2024 |
Andrew Thomson
DFI | Director of Finance/CFO | - | 13/10/2025 |
Renu Vohra
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Evans
BRD | Director/Board Member | - | 21/08/2018 |
Kathryn McKenzie
CHM | Chairman | 65 | 28/11/2023 |
Paul Anderson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/10/26 | Buy | Chief Executive Officer | 117,433 | 0.0162% | ||
| 26/10/26 | Buy | Director | 35,000 | 0.0048% | ||
| 23/10/26 | Buy | Chief Executive Officer | 232,941 | 0.0321% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.40% | +6.50% | -39.49% | -69.92% | 250M | |
| +1.67% | -3.68% | +7.93% | +27.73% | 107B | |
| +2.00% | +7.94% | +5.93% | +121.87% | 103B | |
| +3.13% | -15.45% | +60.54% | +605.86% | 45.05B | |
| +1.18% | +8.03% | +10.16% | +105.72% | 32.96B | |
| +1.43% | +4.57% | +47.13% | +82.02% | 29.77B | |
| +1.58% | +3.53% | +44.66% | +97.26% | 28.12B | |
| +2.00% | +7.48% | +40.80% | +448.80% | 22.55B | |
| -0.37% | +1.18% | -17.81% | -16.07% | 20.05B | |
| -0.78% | -1.42% | -6.93% | +29.88% | 16.76B | |
| Average | +1.44% | +1.01% | +15.29% | +143.32% | 41B | |
| Weighted average by Cap. | +1.67% | +0.84% | +18.76% | +152.18% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.39B 958M 855M 787M 714M 1.35B 89.79B 9.41B 3.75B 48.07B 3.6B 3.52B 151B | 1.41B 977M 872M 803M 728M 1.38B 91.59B 9.6B 3.83B 49.03B 3.67B 3.59B 154B |
| Net income | -2.77M -1.91M -1.71M -1.57M -1.42M -2.7M -179M -18.77M -7.48M -95.86M -7.17M -7.02M -302M | -4.35M -3M -2.68M -2.47M -2.24M -4.24M -281M -29.49M -11.75M -151M -11.27M -11.03M -474M |
| Net Debt | 777M 537M 479M 441M 400M 758M 50.29B 5.27B 2.1B 26.92B 2.01B 1.97B 84.8B | 776M 536M 479M 440M 400M 758M 50.27B 5.27B 2.1B 26.91B 2.01B 1.97B 84.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | $0.5325 | +2.40% | 3,145,308 |
| 09/11/26 | $0.5200 | +4.00% | 6,285,612 |
| 06/11/26 | $0.5000 | +1.01% | 1,024,031 |
| 05/11/26 | $0.4950 | +1.02% | 1,363,252 |
| 04/11/26 | $0.4900 | -2.00% | 2,060,105 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
